Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Roche, Twist Bioscience, Codex DNA, More

Roche Cobas SARS-CoV-2 Variant Set 1 Test

Roche has launched its Cobas SARS-CoV-2 Variant Set 1 Test for research use only to detect mutations in virus variants associated with increased human-to-human transmission. It detects and differentiates three mutations found in the UK B.1.1.7, South Africa B.1.351, and Brazil P.1 variants. Mutations E484K, N501Y, and del 69-70 for these variants are found in the spike protein and may be linked to increased disease transmissibility. 

The RT-PCR test runs on the high-throughput Cobas 6800/8800 systems and contains the necessary primers and probes in the 384-test cassette. 


Twist Bioscience Synthetic RNA Controls for SARS-CoV-2 Variants of Concern

Twist Bioscience has begun shipping new synthetic RNA reference controls for SARS-CoV-2 that include the new B.1.351 and P.1 lineages of the virus identified in South Africa and Brazil, respectively.

Twist is also now offering new stabilized synthetic RNA controls that cover the B.1.1.7 strain that can be shipped and stored at room temperature.


Codex DNA SARS-CoV-2 Synthetic Genomes for UK and South Africa Variants

Codex DNA has released full-length synthetic genomes for the emerging SARS-CoV-2 variants B.1.1.7 and B.1.351, identified in the UK and South Africa, respectively.

The genomes are synthesized de novo on Codex DNA's BioXp 3250 system and can be used in developing vaccines, therapeutics, and diagnostics for COVID-19 research. They can be activated for use in monoclonal antibody therapy or vaccine development or serve as diagnostic controls.


For more new products and services, please visit the New Products page on our website.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.